Kenichi Tanaka to Antifibrinolytic Agents
This is a "connection" page, showing publications Kenichi Tanaka has written about Antifibrinolytic Agents.
Connection Strength
2.553
-
A Pharmacokinetic and Plasmin-Generation Pharmacodynamic Assessment of a Tranexamic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2022 08; 36(8 Pt A):2473-2482.
Score: 0.752
-
A Pharmacokinetic and Pharmacodynamic Investigation of an e-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2021 Feb; 35(2):406-417.
Score: 0.680
-
Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics. Semin Cardiothorac Vasc Anesth. 2018 Jun; 22(2):164-173.
Score: 0.564
-
Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):959-63.
Score: 0.335
-
CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin. J Cardiothorac Vasc Anesth. 2016 Dec; 30(6):1709-1715.
Score: 0.126
-
The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients. Anesth Analg. 2012 Aug; 115(2):244-52.
Score: 0.096